You are here
Small Animal Imaging (In-vivo) Market worth 910.4 Million USD by 2021
This report analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).
Browse 83 market data Tables and 39 Figures spread through 161 Pages and in-depth TOC on "Small Animal Imaging (In-Vivo) Market"
Early buyers will receive 10% customization on this report.
The global small animal imaging market is expected to reach a value of USD 910.4 Million by 2021; growing at a CAGR of 6.2% during 2016-2021.
A number of factors such as technological advancements in the field of molecular imaging, increasing market demand for non-invasive small animal imaging techniques, and growing number of public-private initiatives and funding to support preclinical researches are propelling the growth of the global small animal imaging market. However, factors such as strict regulatory framework that governs preclinical researches, and significant installation and operational costs associated with preclinical imaging modalities are some of the major factors restraining the growth of this market. In addition to this, technological & procedural limitations associated with standalone systems is a major challenge for companies in this market.
On the basis of products, the global small animal imaging market is segmented into two major categories, namely, modality (optical imaging systems, nuclear imaging systems, MRI systems, Ultrasound systems, CT systems, photoacoustic imaging systems, and magnetic particle imaging systems) and reagents (optical imaging reagents, nuclear imaging reagents, MRI contrast agents, ultrasound contrast agents, and CT contrast agents).
Download the PDF Brochure@
The modalities segment is expected to grow at the higher CAGR in the next five years, owing to the extensive application of small animal imaging during preclinical research, high cost of preclinical imaging systems, and development & commercialization of technologically advanced preclinical imaging technologies.
On the basis of geography, small animal imaging market is classified into four regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, small animal imaging market is expected to be dominated by North America owing to factors such as robust R&D infrastructure for life science researches, fast adoption of novel molecular imaging technologies, significant presence of pharmaceutical and biotechnology companies, and increasing preference of end users for multimodality systems.
New product launches and product enhancements are the key growth strategies adopted by major players to develop their positions in the global small animal imaging market. Moreover, strategies such as geographic expansions; and partnerships, agreements, and collaborations; acquisitions were also adopted by a significant number of market players to strengthen their product portfolios and expand their geographic presence in the global small animal imaging market.
As of 2015, PerkinElmer, Inc. (U.S.), Bruker Corporation (U.S.), FUJIFILM Holdings Corporation (Japan), Mediso Ltd. (Hungary), MILabs B.V. (Netherlands), MR Solutions Ltd. (U.K.), Aspect Imaging (Israel), LI-COR Biosciences (U.S.), Trifoil Imaging (U.S.) and Miltenyi Biotec GmbH (Germany) are some key players operating in the global small animal imaging market.
Get the Sample Paged for More Details@
Mr. Shelly Singh
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.